Cabot Corp (CBT)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$81.48+0.36%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · CBT
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $81 CBT trades at 13× p/e, below its 18× p/e peer median. Our $90 fair value sits above the price. It's a high-confidence read. Analysts target $86–$100. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $92.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $86.34 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $82.10 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $11.41 | — | — | TTM | high |
| graham number | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$86.00 – $100.00 (median $92.00) · 5 analysts · as of 2026-08-05
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $69.89 |
| — |
| — |
| TTM |
| high |
| Peer EV/EBITDA | 12M | $150.55 | 12.2 | 13.94 | TTM | high |
| Peer P/FCF | 12M | $140.24 | 26.0 | 5.40 | TTM | high |
| Peer P/E | 12M | $104.20 | 15.0 | 6.94 | ntm analyst | high |
| Peer P/S | 12M | $104.24 | 1.5 | 69.88 | TTM | high |
| PEG | 12M | $76.59 | 11.8 | 6.51 | TTM | high |
| residual income | 12M | $47.42 | — | — | TTM | high |
| Own P/E history | 12M | $86.29 | 13.3 | 6.51 | TTM | high |
| triangulated | 12M | $122.72 | 17.9 | 6.85 | Triangulated | high |
| Peer P/FCF | 3Y | $128.79 | 26.0 | 4.96 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $109.24 | 15.0 | 7.28 | Analyst | medium |
| Peer P/S | 3Y | $113.44 | 1.5 | 76.05 | Analyst | medium |
| PEG | 3Y | $85.61 | 11.8 | 7.28 | Analyst | medium |
| Own P/E history | 3Y | $96.47 | 13.3 | 7.28 | Analyst | medium |
| Peer P/FCF | 5Y | $121.67 | 26.0 | 4.69 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $118.53 | 15.0 | 7.90 | Analyst | high |
| Peer P/S | 5Y | $123.09 | 1.5 | 82.52 | Analyst | high |
| PEG | 5Y | $92.90 | 11.8 | 7.90 | Analyst | high |
| Own P/E history | 5Y | $104.67 | 13.3 | 7.90 | Analyst | high |